A 5-year-old boy with metastasized high-risk neuroblastoma (primary thoracic tumor, multiple osteomedullar metastases; genetics: diploid MYCN, wildtype ALK) was transferred to our center with very good partial response at the end of induction and completely resected primary tumor for consolidation therapy (Figure 1) according to recommendations of the pan-European SIOPEN Group [10] and German Society of Pediatric Oncology and Hematology [11]. The gene discussed is ALK; the disease is neuroblastoma.